Warning letter
Delta Pharma, Inc.: warning letter of Dec 9, 2014
FDA warning letter 441230 · New Orleans District Office
Key facts
| Reference number | 441230 |
|---|---|
| Company | Delta Pharma, Inc. |
| Subject | CGMP/Drug/Prepared, Packed or Held Under Insanitary Conditions/Adulterated |
| Issue date | Dec 9, 2014 |
| Posted date | Dec 23, 2014 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| CFR sections cited | 210, 211.42(c)(10)(iii), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.113(b) |
| Inspection city | Ripley |
| Inspection ZIP | 38663 |
| Inspection start date | Sep 24, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: